Total Payments
$10,511
2023 Payments
$513.44
Companies
26
Transactions
91
Medicare Patients
5,594
Medicare Billing
$430,688
Payment Breakdown by Category
Consulting$4,520 (43.0%)
Food & Beverage$3,408 (32.4%)
Travel$2,219 (21.1%)
Other$350.00 (3.3%)
Education$13.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,520 | 7 | 43.0% |
| Food and Beverage | $3,408 | 72 | 32.4% |
| Travel and Lodging | $2,219 | 9 | 21.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.9% |
| Honoraria | $150.00 | 1 | 1.4% |
| Education | $13.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,229 | 20 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $1,687 | 8 | $0 (2018) |
| CHF Solutions, Inc | $1,622 | 5 | $0 (2018) |
| ABIOMED | $311.85 | 4 | $0 (2023) |
| BIOTRONIK INC. | $201.63 | 2 | $0 (2018) |
| Vifor Pharma, Inc. | $200.00 | 1 | $0 (2021) |
| Nuwellis, Inc. | $197.69 | 1 | $0 (2023) |
| Akcea Therapeutics, Inc. | $150.00 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $135.16 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $129.57 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $513.44 | 5 | Nuwellis, Inc. ($197.69) |
| 2022 | $37.30 | 2 | Abbott Laboratories ($23.41) |
| 2021 | $200.00 | 1 | Vifor Pharma, Inc. ($200.00) |
| 2020 | $564.03 | 4 | Abbott Laboratories ($291.00) |
| 2019 | $74.29 | 4 | Astellas Pharma US Inc ($40.78) |
| 2018 | $5,346 | 47 | Merck Sharp & Dohme Corporation ($1,687) |
| 2017 | $3,775 | 28 | Abbott Laboratories ($3,305) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $40.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2023 | Abbott Laboratories | JETI PERIPHERAL CATHETER (Device) | Food and Beverage | In-kind items and services | $142.08 | General |
| Category: Vascular | ||||||
| 05/17/2023 | Nuwellis, Inc. | Aquadex Smartflow Console (Device) | Food and Beverage | Cash or cash equivalent | $197.69 | General |
| Category: Cardiology | ||||||
| 03/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $119.02 | General |
| Category: Cardiovascular | ||||||
| 01/23/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Heart Failure | ||||||
| 10/16/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Heart Failure | ||||||
| 10/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: Hyperkalemia | ||||||
| 09/30/2020 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 09/15/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $123.03 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/13/2020 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $284.00 | General |
| Category: Heart Failure | ||||||
| 03/13/2020 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Heart Failure | ||||||
| 10/08/2019 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: CARDIOLOGY | ||||||
| 07/27/2019 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2019 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: CARDIOLOGY | ||||||
| 03/29/2019 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOLOGY | ||||||
| 12/13/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Cardiovascular | ||||||
| 12/12/2018 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $129.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2018 | Abbott Laboratories | Cinch Epiducer SCS (Device) | Food and Beverage | In-kind items and services | $126.73 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/01/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.10 | General |
| 10/23/2018 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $119.21 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/22/2018 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $125.88 | General |
| 10/18/2018 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/17/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2018 | CHF Solutions, Inc | Aquadex (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,299 | 1,747 | $247,451 | $89,574 |
| 2022 | 21 | 1,424 | 2,096 | $293,777 | $114,110 |
| 2021 | 20 | 1,412 | 2,097 | $295,081 | $118,532 |
| 2020 | 21 | 1,459 | 2,005 | $287,183 | $108,472 |
Total Patients
5,594
Total Services
7,945
Medicare Billing
$430,688
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 191 | 381 | $69,385 | $25,935 | 37.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 133 | $30,036 | $12,116 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 182 | $33,536 | $11,790 | 35.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 125 | 130 | $19,666 | $6,304 | 32.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 96 | 96 | $14,736 | $5,317 | 36.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 98 | 100 | $13,980 | $4,680 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $11,434 | $3,692 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 33 | 34 | $9,176 | $3,497 | 38.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 22 | $7,952 | $2,853 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 19 | 19 | $6,748 | $2,518 | 37.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 39 | $6,103 | $2,397 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 50 | $6,151 | $2,168 | 35.3% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 16 | 53 | $4,389 | $1,566 | 35.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 204 | 236 | $4,248 | $1,234 | 29.1% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Facility | 2023 | 26 | 40 | $2,760 | $1,089 | 39.5% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 23 | 26 | $1,840 | $718.38 | 39.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 67 | 67 | $2,215 | $691.47 | 31.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 31 | 33 | $1,924 | $597.06 | 31.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 13 | 20 | $511.00 | $192.40 | 37.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 14 | 14 | $473.00 | $151.48 | 32.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 28 | 30 | $188.00 | $66.64 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 204 | 439 | $69,801 | $30,006 | 43.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 268 | $56,280 | $21,611 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 181 | $29,079 | $11,682 | 40.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 20 | 37 | $16,613 | $6,300 | 37.9% |
About Dr. Wayne Old, MD
Dr. Wayne Old, MD is a Cardiovascular Disease healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336115799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Old, MD has received a total of $10,511 in payments from pharmaceutical and medical device companies, with $513.44 received in 2023. These payments were reported across 91 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($4,520).
As a Medicare-enrolled provider, Old has provided services to 5,594 Medicare beneficiaries, totaling 7,945 services with total Medicare billing of $430,688. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Advanced Heart Failure and Transplant Cardiology
- Location Chesapeake, VA
- Active Since 02/27/2006
- Last Updated 05/03/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336115799
Products in Payments
- CardioMEMS HF System (Device) $4,651
- MK-1242 (Drug) $1,687
- Aquadex (Device) $1,622
- Impella (Device) $311.85
- Veltassa (Drug) $200.00
- Aquadex Smartflow Console (Device) $197.69
- Circulatory Support (Device) $155.98
- TEGSEDI (Drug) $150.00
- JETI PERIPHERAL CATHETER (Device) $142.08
- ENTRESTO (Drug) $129.57
- Cinch Epiducer SCS (Device) $126.73
- NEXLIZET (Drug) $123.03
- CAMZYOS (Drug) $119.02
- HeartMate 3 Left Ventricular Dev (Device) $115.99
- MULTAQ (Drug) $88.84
- PRADAXA (Drug) $61.88
- PRALUENT ALIROCUMAB INJECTION (Biological) $46.70
- LEXISCAN (Drug) $40.78
- BRILINTA (Drug) $38.19
- CARDIOMEMS (Device) $37.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chesapeake
Dr. John Herre, M.d, M.D
Cardiovascular Disease — Payments: $387,538
Cardiovascular Disease $387,538
Dr. Venkat Iyer, M.d, M.D
Cardiovascular Disease — Payments: $136,654
Cardiovascular Disease $136,654
Dr. Dhananjai Menzies, M.d, M.D
Cardiovascular Disease — Payments: $57,668
Cardiovascular Disease $57,668
Vadim Levin, M.d, M.D
Cardiovascular Disease — Payments: $32,111
Cardiovascular Disease $32,111
Frank Amico, Do, DO
Cardiovascular Disease — Payments: $16,747
Cardiovascular Disease $16,747
Mohsin Chowdhury, M.d, M.D
Cardiovascular Disease — Payments: $16,552
Cardiovascular Disease $16,552